Knowledge, attitude, beliefs, and behaviors of Saudi pregnant women towards Tdap vaccine Authors: Joud S Makki, Diana N Hujelan, Hala K Jamous, Anhar M Alheji, Noof M Alharbi, Asia M Kalantan, Nadia Alghilan Published: 2026 ABSTRACT ABSTRACTVaccination against tetanus, diphtheria, and pertussis (Tdap) is essential to protecting mothers and infants against these severe diseases. In the Kingdom of Saudi Arabia, vaccination coverage among pregnant women remains suboptimal, with only 25–30% of pregnant females. The analysis of their knowledge, attitudes, and behaviors concerning the vaccine will, in turn, help formulate strategies to increase the vaccination rate. A cross-sectional study was carried out on 398 pregnant Saudi women aged 18–40 y using a validated questionnaire examining their knowledge of the vaccine. The study demonstrated that there were significant gaps in knowledge in that 36% of the participants correctly identified pertussis as a highly contagious disease yet preventable by vaccination, while 22% identified its severity in newborns. Better knowledge was associated with higher education attainment, and prior knowledge of vaccination against pertussis in adults was associated with more positive attitudes. A more significant majority of participants reported positive attitudes about vaccination overall, but 71% of them expressed concerns about side effects and safety. The findings indicate a need for targeted educational interventions as far as safety and knowledge gaps are concerned. Improving communication by health providers can increase vaccination uptake among pregnant women to ensure an increase in the protection of mothers and infants against whooping cough.KEYWORDS: Maternal immunization, pregnancy, Saudi pregnant, Tdap, vaccine Introduction Vaccination against tetanus, diphtheria, and pertussis (Tdap) has become essential to maternal immunization programs to protect the mother and the infant against these vaccine-preventable diseases. Description of knowledge about, attitude toward, belief, and behavior of pregnant women regarding Tdap vaccination will provide valuable inputs to policymakers in improving vaccination coverage and, thereby, overall population health in Saudi Arabia, where health policies are still evolving to enhance maternal and child health. Recent studies conducted in the last couple of years across several regions, including Saudi Arabia, have revealed suboptimal vaccination coverage rates for Tdap during pregnancy. A recent study found that only 25% of pregnant women in Riyadh received vaccination with Tdap, although its effectiveness has been established in preventing neonatal pertussis.1 According to the study by Alzahrani et al. in 2021, the vaccination rates in Jeddah are estimated at only about 30%; this shows a significant gap in maternal immunization practices.2 The World Health Organization recommends giving every pregnant woman the Tdap vaccine during every pregnancy to afford newborn protection against infection passively.3 Awareness of the Tdap vaccine among pregnant women in Saudi Arabia varies significantly. For example, Al-Mulhim et al. 2020, established that a relatively large proportion of women were unaware of the benefits to be accrued from the vaccine, which relates directly and invariably to their decision to get vaccinated or not.4 It has also been indicated recently by Al-Bader et al. in 2023 that misconceptions related to the safety and efficiency of vaccines themselves are highly prevalent and further influence attitudes and beliefs regarding immunization.5 The perceived risk of adverse effects and belief in alternative preventive measures have been thought to cause this hesitancy in this demographic group.6,7 Other major contributing factors to vaccine uptake are behavioral in nature. A survey conducted in 2019 by Al-Dosari et al. identified the major challenges as poor access to vaccination services and a lack of recommendations from healthcare providers.8 In research conducted in 2022, Al-Qahtani et al. note that people who were positive in attitude and more knowledgeable about the vaccine were found to be more likely to get vaccinations.9 The issues under consideration require multifaceted approaches: education, improved access to healthcare, and targeted interventions. Findings from this study are expected to give an idea about the current knowledge, attitude, belief, and behavior regarding the Tdap vaccine among pregnant women in Saudi Arabia and identify strategies that could enhance vaccination coverage. Methods This study adopted a cross-sectional design to study the knowledge, attitudes, and beliefs of Saudi pregnant women regarding the Tdap vaccine. The target population involved 398 pregnant Saudi women aged between 18 and 40 from Saudi Arabia. To ensure that the target demographic in question is only surveyed, non-pregnant females and males are excluded. Ethical considerations All participants involved were provided with a consent forms. Participation in the study was voluntary, and participants were able to withdraw at any time. Anonymity and confidentiality were ensured throughout the study, with personal identification data being excluded. Only the principal investigator and co-investigators had access to the collected data. Permission to conduct this study was granted from King Abdullah International Medical Research Center (KAIMRC). (IRB/2291/23). (Reference number: RYD-23-419812-107753). The tool adapted for this study was drawn from similar studies that are validated and reasonably reliable.10,11 The pre-testing and expert review were done to ensure that this instrument is applicable to our study since, in previous studies, it has been fairly useful in assessing knowledge, attitude, and behavior about Tdap vaccination. The questionnaire will cover demographics, general information and awareness, specific knowledge about Tdap, attitudes and beliefs, and information sources. Results The research queried 398 pregnant women, 40% of whom were between 18 and 30 y old and had a university-level education (63%). Most had been pregnant 1–5 times (88%), with 16% having no previous births. Information about Tdap vaccinations came from the doctors or nurses for 55%, while 19% reported not getting any vaccination information. General awareness of whooping cough was medium, as one-half of the participants reported having heard of it, but 90% had never caught the disease. The danger of the disease to a newborn was variable; 17% believed it was very high, and 49% were not sure. Most women, 57%, were unaware of any adult pertussis vaccine; thus, further education is needed (Table 1). Table 1.Demographic characteristics, educational levels, and pertussis awareness among pregnant women.CharacteristicN = 398aAge 18–30160 (40%)31–35116 (29%)36–40122 (31%)Educational level less than secondary school28 (7.0%)Secondary school90 (23%)University education251 (63%)Higher education29 (7.3%)Number of pregnancy 1–5 times349 (88%)6–10 times49 (12%)Number of birth None65 (16%)1–5 times311 (78%)6–10 times22 (5.5%)Source of information about vaccinations curriculum2 (0.5%)Doctor/Nurse218 (55%)Friends and family27 (6.8%)Internet54 (14%)Media (TV, newspapers…)22 (5.5%)I have not received any information regarding vaccinations74 (19%)Unknown1previous knowledge of whooping cough No174 (44%)Yes198 (50%)I don’t know26 (6.5%)History of whooping cough No357 (90%)Yes12 (3.0%)I don’t know29 (7.3%)How dangerous do you think whooping cough (pertussis) is for a baby after birth? Very high68 (17%)Fairly high65 (16%)Medium48 (12%)Not sure195 (49%)Low13 (3.3%)Very low9 (2.3%)previous knowledge of whooping cough vaccination for adults No227 (57%)Yes67 (17%)I don’t know104 (26%)an (%); Median (IQR). Demographic characteristics, educational levels, and pertussis awareness among pregnant women. an (%); Median (IQR). It has been indicated that over half of them correctly identified pertussis as a respiratory infection, including pertussis-whooping cough and its vaccination. Only 42%, however, identified that it was not a viral infection. About 36% realized that it is highly contagious and can be prevented with vaccination, whereas only 22% realized the capability of death among newborn babies. The knowledge of transmitting protective antibodies from mother to child during pregnancy or breastfeeding was low, with 28% knowledgeable and 68% unaware. Similarly, only 30% correctly identified the family members as the primary source of infection for newborns. Knowledge about pertussis-related complications and vaccination protocols could have been more relevant. Only 13% knew that long-term complications may include learning and behavioral problems, and only 13% realized that adults could get pertussis even if they had been vaccinated as infants. Knowledge of routine shots was equally lacking: 19% reported that infants and children routinely get pertussis vaccination, and 12% knew that the vaccine is routinely given to adolescents and adults. The vaccination safety in children of pregnant women and those with minor illnesses was known only by 24% and 12%, respectively. Correctly, 43% of them identified that all recommended vaccinations can be given to breastfed babies, and 17% mistakenly reported that too many vaccinations can overload the immune system (Table 2). Table 2.Awareness of pertussis and its vaccination among pregnant women.CharacteristicCorrectIncorrectI don’t knowPertussis (whooping cough) is an infection of the respiratory system, causing severe coughing followed by a high-pitched whooping sound that sounds like “morning rooster227 (57%)7 (1.8%)164 (41%)A virus causes pertussis (whooping cough)168 (42%)15 (3.8%)215 (54%)Pertussis (whooping cough) is one of the most contagious diseases that can be prevented by vaccination142 (36%)228 (57%)28 (7.0%)Pertussis (whooping cough) can kill newborns who are infected with it87 (22%)16 (4.0%)295 (74%)Whooping cough can be transmitted to the fetus during pregnancy58 (15%)32 (8.0%)308 (77%)Whooping cough can be transmitted to the baby during birth68 (17%)22 (5.5%)308 (77%)Pregnant and breastfeeding women can pass antibodies that protect their babies from whooping cough (pertussis) through the placenta or during breastfeeding110 (28%)16 (4.0%)272 (68%)Newborns get whooping cough (pertussis) through infection from the mother or a family member120 (30%)260 (65%)18 (4.5%)Most deaths from whooping cough in children are those under one year old72 (18%)17 (4.3%)309 (78%)Newborns who have had pertussis (whooping cough) are at increased risk for learning and behavioral problems later in life50 (13%)46 (12%)302 (76%)Teenagers and adults can get whooping cough (pertussis)163 (41%)15 (3.8%)220 (55%)Adults can get whooping cough (pertussis) even if they were vaccinated as infants52 (13%)56 (14%)290 (73%)Infants and children are routinely vaccinated against pertussis (whooping cough)75 (19%)47 (12%)276 (69%)Adolescents and adults are routinely vaccinated against pertussis (whooping cough)49 (12%)60 (15%)289 (73%)Infants under 2 months of age cannot receive the pertussis (whooping cough) vaccine54 (14%)35 (8.8%)309 (78%)It is safe to give the pertussis (whooping cough) vaccine to children of pregnant mothers97 (24%)22 (5.5%)279 (70%)It is safe to give the pertussis (whooping cough) vaccine to children with minor illnesses such as ear infections]49 (12%)58 (15%)291 (73%)Breastfed infants can receive all recommended vaccinations171 (43%)15 (3.8%)212 (53%)Getting too many vaccinations can overwhelm and weaken the immune system66 (17%)121 (30%)211 (53%)n (%). Awareness of pertussis and its vaccination among pregnant women. n (%). 27.1% of respondents disagreed that whooping cough is rare. In comparison, 33.7% disagreed that it is better to get whooping cough naturally than to get vaccinated, while 36.2% agreed that children should be wholly immunized against whooping cough by six months of age, with 18.6% strongly agreeing. 34.4% agreed that vaccination against whooping cough should be carried out among parents and close contacts to the baby. Moreover, 35.7% of the participants held a neutral opinion on whether whooping cough poses a severe threat to young children, while 16.3% strongly agreed. The pertussis vaccine, on the other hand, was said to be effective by 30.4% of the respondents, while 37.7% agreed and 18.8% strongly agreed. On the safety of vaccination during pregnancy, 53.7% agreed, while 13.8% strongly agreed. Waiting after the first trimester before vaccinations showed 43.0% disagreement, while those waiting until birth showed 42.0% disagreed. About 42% were indifferent to the best way to avoid vaccinations during pregnancy, while 8% strongly agreed. 24.9% and 11.3% agreed that women should wait immediately after birth to get vaccinated. Most, 48.5%, were neutral in the thought that vaccination during pregnancy can lead to congenital disabilities, while 14.3 and 9.3% disagreed and strongly disagreed. About 14.8% disagreed, and 9.5% strongly disagreed that vaccines can cause autoimmune diseases. In comparison, 10% and 9.3% disagreed and strongly disagreed that it is better to take a chance on whooping cough than to get vaccinated during pregnancy (Figure 1). Pertussis vaccination attitude among pregnant women. Nearly a fourth of women had good knowledge of the Tdap vaccine and 95.2% had positive attitudes toward it (Figure 2). Level of pertussis vaccination awareness and attitude among pregnant women. About 66% of the pregnant women surveyed, felt that they got enough information from the doctor to decide to take up the whooping cough vaccination during pregnancy. In comparison, about 14% did not feel they were given enough information. Of these, the willingness to get the vaccine itself varied: 62% reported that they would be willing to get vaccinated right after birth to protect their newborn, 55% would be willing to get vaccinated during pregnancy if doing so could protect their child, and 67% were considering vaccination before pregnancy for future protection. If advised about safety by their physician, 63% would be willing to get vaccinated during pregnancy, 13% were unwilling to do so, and 24% were not sure. The perceived barriers included concerns about possible side effects for themselves 71%, their child 64%, and the overall safety of the vaccine 62%. Besides, 52% were concerned about the risk of not being vaccinated for themselves and 44% for their child. These results emphasize the need to discuss safety concerns and provide information appropriately to increase vaccine uptake among pregnant women (Table 3). Table 3.Willingness to receive pertussis vaccination during and after pregnancy and perceived safety and barriers to pertussis vaccination among pregnant women.CharacteristicN = 398aI have enough information from my doctor to decide whether or not to get the whooping cough vaccine during pregnancy. No57 (14%)Yes263 (66%)I don’t know78 (20%)If it is known, during pregnancy, that you can protect your newborn from whooping cough by getting vaccinated right after birth (and there is no known risk to you or your baby), would you be willing to get vaccinated after birth? No43 (11%)Yes247 (62%)I don’t know108 (27%)If it is known, while you are pregnant, that you can protect your newborn from whooping cough only by vaccinating your baby during pregnancy (and there is no known risk to you or your baby), would you want to be vaccinated during pregnancy? No66 (17%)Yes218 (55%)I don’t know114 (29%)If it is known, while you are considering pregnancy, that you can protect your newborn from whooping cough in the future by vaccinating before pregnancy (and there is no known risk to you or your baby), would you want to be vaccinated before pregnancy? No40 (10%)Yes267 (67%)I don’t know91 (23%)If your doctor tells you that the pertussis vaccine is safe and recommended during pregnancy, would you want to be vaccinated? No52 (13%)Yes250 (63%)I don’t know96 (24%)Perceived barriers against vaccination Side effects I may experience if I get the vaccine283 (71%)Side effects my child may experience if I get the vaccine189 (47%)How safe is the vaccine for me248 (62%)How safe is the vaccine for my child253 (64%)The risk to me if I don’t get the vaccine207 (52%)The risk to my child if I don’t get the vaccine177 (44%)an (%). Willingness to receive pertussis vaccination during and after pregnancy and perceived safety and barriers to pertussis vaccination among pregnant women. an (%). The determinants of knowledge about the Tdap vaccination showed various significant associations. Older age had no significant correlation with increased vaccine knowledge, p = .9. Women with secondary school education had considerably lower knowledge than those with less than secondary school education. Beta: − 2.1, 95% CI: − 3.7, − 0.53, p = .009. No statistically significant associations were established between the number of pregnancies and knowledge of the Tdap vaccination: Beta = −0.08, 95% CI: −0.45 to 0.29, p = .7, and number of births, Beta = 0.15, 95% CI: −0.25 to 0.56, p = .5. Previous awareness of whooping cough was strongly associated with higher knowledge, while women previously aware of the pertussis vaccine for adults showed higher knowledge significantly, Beta: 1.9, 95% CI: 0.88, 3.0, p < .001. On the other hand, a history of whooping cough did not show a significant association with knowledge, Beta: 1.1, 95% CI: −1.0, 3.3, p = .3. These findings indicate how awareness and education in the past led to improved knowledge about Tdap vaccination (Table 4). Table 4.Determinants of knowledge of Tdap vaccination.CharacteristicBeta95% CIp-valueAge 18–30–– 31–35−0.07−1.0, 0.89.936–40−0.41−1.5, 0.66.4Educational level less than secondary school–– Higher education−0.67−2.7, 1.4.5Secondary school−2.1−3.7, −0.53.009University−1.2−2.7, 0.31.12Number of pregnancy−0.08−0.45, 0.29.7Number of birth0.15−0.25, 0.56.5Previous awareness of whooping cough No–– I don’t know0.20−1.4, 1.8.8Yes2.11.3, 3.0<.001History of whooping cough No–– Yes1.1−1.0, 3.3.3I don’t know−1.2−2.6, 0.29.12previous knowledge of whooping cough vaccination for adults No–– I don’t know−0.85−1.7, 0.02.056Bold values indicate statistical significance (p < 0.05). Determinants of knowledge of Tdap vaccination. Bold values indicate statistical significance (p < 0.05). The analysis of determinants of attitudes to the Tdap vaccination revealed that the factors of older age and pre-interview knowledge on adult pertussis vaccination significantly contributed to the variation in attitudes. More specifically, women aged 31–35 y had a higher positive attitude toward the vaccine (Beta: 1.8, 95% CI: 0.07, 3.5), as compared to the younger group of women aged 18–30 y, at a p-value of .042. However, regarding other age groups, no women aged 36–40 y or older showed significant attitude changes as compared to the younger groups of women. Additionally, it was found that the women who had previously known about whooping cough vaccination for adults expressed a significantly better attitude toward the vaccination (mean 3.6, 95% CI: 1.7–5.5) than those who never knew about vaccination. The significance of this relation is less than 0.001. The variables considered were educational level, number of pregnancies, and history of whooping cough, which did not significantly affect attitude toward the vaccine. These findings underline how vaccination against pertussis in adulthood education is relevant to positive attitudes toward vaccination (Table 5). Table 5.Determinants of attitude towards Tdap vaccination.CharacteristicBeta95% CIp-valueAge 18–30–– 31–351.80.07, 3.5.04236–401.1−0.87, 3.0.3Educational level Less than secondary school–– Higher education−2.2−5.9, 1.5.2Secondary school−0.54−3.4, 2.3.7University−1.1−3.9, 1.6.4Number of pregnancy0.08−0.59, 0.74.8Number of birth−0.40−1.1, 0.33.3Previous awareness of whooping cough No–– I don’t know−0.59−3.4, 2.2.7Yes1.4−0.17, 2.9.081History of whooping cough No–– I don’t know−1.3−4.0, 1.3.3Yes−1.7−5.6, 2.2.4previous knowledge of whooping cough vaccination for adults No–– I don’t know−0.04−1.6, 1.5>.9Yes3.61.7, 5.5<.001Bold values indicate statistical significance (p < 0.05). Determinants of attitude towards Tdap vaccination. Bold values indicate statistical significance (p < 0.05). Women with good knowledge regarding Tdap vaccination had a higher attitude toward it than those with poor knowledge (mean 48.4 vs 44.9, p-value <.001) (Figure 3). Association between knowledge of pertussis vaccination and attitude toward it. Discussion The analysis indicated significant knowledge gaps exist concerning pertussis and the Tdap vaccine. Whereas most participants recognized pertussis as a respiratory infection, there is still a perceived contagiousness and the perceived seriousness of the disease. Only 36% knew that pertussis is a highly contagious disease and can be prevented through vaccination, and only 22% recognized it could be lethal to a newborn baby. Gravida protection by transferring protective antibodies during pregnancy and breastfeeding was similarly low; only 28% recognized this among the women. Further, only 30% of the women correctly pointed out that the usual source of the infection in the newborn is the family members. These findings agree with other studies that have emphasized the general shortcomings of knowledge concerning vaccine-preventable diseases and the methods of their transmission.7,12 The educational level was a vital influencing factor in knowledge about the Tdap vaccine. Less than secondary school education knowledge was considerably lower for women who had secondary school education. This is in concurrence with the general indication in existing literature that higher educational attainment is associated with better health literacy and vaccine knowledge.8,9 Variables such as age, number of pregnancies, and number of births do not appear to be significantly associated with pregnant women’s knowledge of Tdap; prior awareness and focused educational effort thus play an even more significant role in shaping vaccine knowledge. It was determined that the previous knowledge about vaccination against pertussis in adults strongly impacts the attitudes of the study participants toward the Tdap vaccine. The attitude to this vaccine was more positive in persons who knew it in advance. This finding underlines the importance of targeted education campaigns in improving vaccine acceptance.10 The older group of women in this sample studied, aged 31–35 y, had more positive attitudes toward vaccination, perhaps due to a longer experience of life and perceived vulnerability.11 The perceived barriers to vaccination were primarily concerns about the after-effects and vaccine safety. This is consistent with other studies that noted safety concerns as significant deterrents to vaccine uptake.12,13 However, despite concern over safety issues, a substantial proportion of women still professed their willingness to get vaccinated if assured by their healthcare provider that the vaccine is safe. This underlines again the importance of health professional communication in reassuring safety concerns and facilitating vaccine uptake.14,15 The research also established that many women felt they were not being given enough information on vaccination decisions by health professionals. This communication gap indicates that better educational efforts and consultations are needed to make pregnant women aware of the efficacy and safety of the Tdap vaccine.16,17 There are several limitations that have to be taken into consideration: reliance on self-reported data can provide biases for response since participants may under- or overreport their knowledge and attitudes regarding pertussis vaccination. The study design is cross-sectional; therefore, any establishment of causation between educational interventions and changes in vaccine knowledge or attitude is limited. The sample is also geographically and demographically specific, with implications in the generalizability of these findings to other populations. In addition, though the current study can capture perceptions and awareness at a fixed point in time, it does not provide any information on changes in either knowledge or attitudes over time or as a result of education efforts. Conclusion The current study identified the significant gaps in knowledge about pertussis vaccination among pregnant women and found that many women were unaware of the severity of the disease, the transmission of the disease, and the benefits entailed with the Tdap vaccine. Education level significantly plays a determining role in vaccine knowledge; thus, specific educational interventions must be targeted toward responding to identified gaps in knowledge. It was reported that positive attitudes were noticed among women with previous awareness of adult pertussis vaccination and those of an older age. However, many are pretty worried about the safety and side effects of the vaccine. Improvement in communication and education through health care providers is necessary to increase vaccine uptake and protect mothers and newborns against whooping cough. Biography Joud S. Makki is a medical intern currently completing my program at MNGHA. She graduated with honors from college of medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia, with a Doctor of Medicine degree. Her research interests include internal medicine, public health, obstetrics and gynecology. Joud is dedicated to improving patient care through evidence-based practices and has contributed to several publications in peer-reviewed journals. She is also involved in community outreach programs aimed at promoting health education. Funding Statement The author(s) reported there is no funding associated with the work featured in this article. Disclosure statement No potential conflict of interest was reported by the author(s). References